assetIcon

Novo Nordisk A/S (NVO) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Overview

Financial

Technicals

Analysis

Corporate Action

About

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.


Technical Indicators

|

|

|

No data available

There are no indicators for the selected timeframe.


Performance

NVO ROI

arrow
-28.47%

% from 52W High

-34.91%
$129.89

52W Low: $87.78

03 Oct 2023

52W High: $199.54

11 Sep 2023


Key Stats

Market Cap
Market Cap
$598.23B
Sector
Sector
Health
3M Drawdown
3M Drawdown
-
Enterprise Value
Enterprise Value
$597.42B
Dividend Yield
Dividend Yield
1.03%
Typical Hold Time
Typical Hold Time
578 days

People Also Bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions



Let’s trade or invest in this asset by signing up or logging in!

register_card

Let’s trade or invest in this asset by signing up or logging in!

You can also download our app!

item
item
item